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Background: Aseptic loosening of total joint replacements (TJRs) continues to be the main cause of implant
failures. The socioeconomic impact of surgical revisions is hugely significant; in the United Kingdom alone, it is
estimated that £137 m is spent annually on revision arthroplasties. Enhancing the longevity of titanium implants
will help reduce the incidence and overall cost of failed devices.
Methods: In realising the development of a superior titanium technology, we exploited the natural affinity of ti-
tanium for phosphonic acids and developed a facile means of coating the metal with (3S)1-fluoro-3-hydroxy-4-
(oleoyloxy)butyl-1-phosphonate (FHBP), a phosphatase-resistant analogue of lysophosphatidic acid (LPA).
Importantly LPA and selected LPA analogues like FHBP synergistically cooperate with calcitriol to promote
human osteoblast formation and maturation.
Results: Herein, we provide evidence that simply immersing titanium in aqueous solutions of FHBP afforded a
surface that was superior to unmodified metal at enhancing osteoblast maturation. Importantly, FHBP-func-
tionalised titanium remained stable to 2 years of ambient storage, resisted ~35 kGy of gamma irradiation and
survived implantation into a bone substitute (Sawbone™) and irrigation.
Conclusion: The facile step we have taken to modify titanium and the robustness of the final surface finish are
appealing properties that are likely to attract the attention of implant manufacturers in the future.
The translational potential of this article: We have generated a functionalised titanium (Ti) surface by simply
immersing Ti in aqueous solutions of a bioactive lipid. As a facile procedure it will have greater appeal to implant
manufacturers compared to onerous and costly developmental processes.Introduction
Since the 1970s, titanium and its alloys, e.g. Ti6Al4V, have found
widespread application in medicine and dentistry. Examples of Ti6Al4V
usage in biomedical settings include dental and orthopaedic implants,
e.g. prosthetic joint replacements. The impressive strength, corrosion
resistance and biocompatibility place Ti6Al4V as a choice material for
implantology [1]. In spite of new approaches in the manufacture and
finish of Ti6Al4V total joint replacements (TJRs) approximately 7% will
fail within the lifetime of the patient. Themajor cause of Ti6Al4V implant
failure is aseptic loosening (~80% of all revisions), which likely is aciences, University of the West o
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current UK’s National Health Service tariffs (https://improvement.nhs.
uk/resources/national-tariff/), the socioeconomic impact of aseptic
loosening is significant; indeed, the cost incurred to replace failed TJRs in
2017 was approximately £137 m.
Ti6Al4V is biologically inert, which reduces the interaction of the
metal with host bone tissue [3]. Encouraging host cell responses
conducive to bolstering early integration into bone stems from the use of
osteoconductive Ti6Al4V coatings. It is widely agreed that new Ti6Al4V
technologies be developed that exhibit greater bioactivity to promote
osseointegration [4], an event predicted to improve TJR longevity. Onef England, Coldharbour Lane, Bristol, BS16 1QY, UK.
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agents that promote osteoblast responses synonymous with bone matrix
formation and mineralisation (osteogenesis). To this end, calcium phos-
phates, in particular, hydroxyapatite (HAp) have been adopted as
Ti6Al4V coatings because of their osteoconductive properties, which
helps augment osseointegration [5]. The steps taken to coat Ti6Al4Vwith
HAp are wide ranging and include sputter coating [6], electrophoretic
deposition [7], hot isostatic pressing [8] and plasma spraying [9].
However, in spite of its enormous popularity, it is important to note
that HAp will dissolve due to poor crystallised structure [10,11], which,
in turn, compromises its adherence to Ti6Al4V leading to implant failure
[11,12]. Low HAp coating adhesion is regarded by some to be of sig-
nificant concern in the wider commercialisation of implantable devices
[13–16]. Alternative solutions to HAp for improving Ti6Al4V perfor-
mance have been sought and include biological coatings, e.g. parathyroid
hormone. A detailed account as to the preparation of these surfaces is
beyond the scope of this work, but a summary of those Ti6Al4V tech-
nologies generated over the past five years is provided (Table 1). It is
noteworthy that in the majority of cases, the approaches taken towards
developing these Ti6Al4V devices involve a multistep approach, some-
times requiring specialised techniques and/or noxious reagents. Clearly,
there is scope to consider simpler and safer steps towards coating
Ti6Al4V with osteoconductive, bioactive agents. To this end, we haveTable 1
Contemporary developments in titanium surface modification aimed at
improving osseointegration.







Human whole blood Titanium discs immersed in
whole blood with shaking at





Titanium steeped in a
rapamycin-hyaluronate
solution with ultrasonication
for 12hr followed by a PBS



























with 0.1 M FeCl3 for 24 h at
200 C.
Pure [51]
Phytic acid and Ca(OH)2 Hydrothermal treatment (70
C) of titanium using an
aqueous mixture of phytic
acid and Ca(OH)2 for 24 h.
Grade 4 [52]
Zinc and strontium Titanium surface






Calcium phosphate Three-step soaking process;
immersion in warm (37 C)
phosphate solution for 30
min, a centrifugation step
followed by CaCl2 for 120
min at 80 C.
Grade 4 [54]
Lithium chloride Immersion of titanium in a
hot (120 C) LiOH solution
(50 mM) for 12 h.
Grade 2 [55]
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focussed on lysophosphatidic acid (LPA) and selected, metabolically
stabilised LPA analogues following our discovery that LPA converged
with calcitriol (1,25D) in promoting human osteoblast formation and
maturation [17–20]. Since osteoblast maturation is the limiting step to
bone matrix calcification, agents that have the capacity to enhance this
event are attractive candidates in contemporary bone biomaterial design.
The LPAs are pleiotropic lysophospholipid growth factors, each
composed of a fatty acyl chain, glycerol backbone and a polar phosphate
head group; different LPAs vary according to acyl chain length and de-
gree of saturation [21].
As phosphonic acids (PAs), the LPAs will have a natural affinity for
titanium oxide (TiO2), the natural surface finish of the metal. The
interaction between PAs and TiO2 results in the formation of stable
phosphonate bonds [22,23], affording robust coatings of self-assembled
layers (Fig. 1). Given the tenacity of PAs for TiO2 and the synergistic
effect of LPA and 1,25D upon osteoblast maturation, a potential candi-
date Ti6Al4V coating for dental and orthopaedic applications could be a
potent, metabolically stabilised LPA analogue. Herein, we focus on the
LPA analogue (3S)1-fluoro-3-hydroxy-4-(oleoyloxy)butyl-1-phosphonate
(FHBP), which we have found works very well with active vitamin D
metabolites to secure human osteoblast maturation [24–26]. In devel-
oping our FHBP-Ti6Al4V, we provide evidence for a facile coating pro-
cess wherein an aqueous solution of the lipid is applied to the metal in
one step under ambient conditions. Herein we provide sound evidence
for the biocompatibility and stability of the coating to prolonged storage,
sterilisation and physical insult.
Materials & methods
General
Unless stated otherwise, all reagents were of analytical grade and
purchased from Sigma (Poole, UK).
Physiochemical characterisation of FHBP-functionalised Ti6Al4V
Magnetic sector secondary ion mass spectrometry
Secondary ion mass spectrometry (SIMS) analysis concentrated on
control (blank) and 2 μM FHBP-coated specimens. The FHBP steeping
concentration was informed from our previous work pertaining to the
FHBP-functionalisation of HAp [27]. Two different initial surface finishes
of the Ti6Al4V discs were used, as-received (presenting a relatively rough
surface) and polished (smooth at the micro-scale). SIMS analysis was
performed using a magnetic sector instrument comprising an FEI Com-
pany (now Thermo Fisher Scientific) (electronic variable aperture type)
focused gallium ion gun fitted to a VG 7035 double-focusing magnetic
sector mass spectrometer. Mass spectra, secondary ion images and depth
profiles were obtained by scanning the focused gallium ion beam of 25
keV energy over the specimens and collecting the resulting secondary
ions. SIMS can operate in positive and negative secondary ion mode.
Surface spectra were captured in both modes, while depth profiles and
ion maps were acquired mainly in negative ion mode in order to capture
the fluorine, phosphate and oxygen ions, which are generally negatively
charged.
Mass spectra were generally captured using a beam current of 100 pA
scanned over a region of approximately 400 μm  400 μm. For each
spectrum, a mass range of 0Da–100Da was recorded, with a step size of
0.05Da and a dwell time of 100 ms per step. Under these conditions, it is
estimated that during the acquisition of one spectrum, the target material
would have sputtered to a depth of 0.03 nm. This is expected to be a small
proportion of the coating thickness. The spectra, therefore, represent the
species present at the specimen surfaces. In the SIMS measurements, it is
the peak at 19Da in the negative spectra, assigned to fluorine, which is
primarily indicative of the presence/absence of FHBP.
Secondary electron and secondary ion images were acquired in 640px
 480px format using a pixel dwell time of 0.2 ms–0.8 ms. The secondary
Figure 1. Overview of the predicted modes of
FHBP binding at a titanium surface – (3S) 1-fluoro-
3-hydroxy-4-(oleoyloxy)butyl-1-phosphonate (FHBP,
sodium salt) is a phosphatase-resistant analogue of
lysophosphatidic acid (LPA). As a phosphonic acid, it
has a natural affinity for titanium. Depicted are the
likely modes of binding; (1) monodentate, (2) and (3)
bridging bidentate, (4) bridging tridentate, and (5),
chelating bidentate. Phosphonic acid–titanium in-
teractions afford robust bonding in the generation of
self-assembled (mono)layers (Adapted from Ref. [22]).
A.I. Shiel et al. Journal of Orthopaedic Translation xxx (xxxx) xxxion species F and O were chosen for mapping, representing fluorine
and oxygen, respectively. A secondary electron image accompanied the
ion maps, showing topographical contrast.
SIMS specimens were analysed as-received and were stored between
measurements under ambient laboratory conditions.
High-speed atomic force microscopy
The high-speed atomic force microscope (HS-AFM) used in this work
was a custom-built, contact mode system, designed and developed in-
house, permitting rapid data acquisition over large areas with sub-
nanometre topological height accuracy while minimising many of the
drift and noise effects that typically plague conventional AFMs [29–31].
This microscope utilised a very low spring constant silicon nitride tri-
angle cantilever (Bruker Nano: MSNL; 0.01N/m - 0.03N/m spring con-
stant; tip radius 2 nm nominal, 12 nm maximum). The cantilever vertical
deflection was measured by a 2.5 MHz bandwidth laser Doppler vibr-
ometer (Polytec CLV-2534) using a height decoder module. Specimens
were translated in the fast (1000 Hz) and slow (1 Hz–4 Hz) scan di-
rections by a piezo-actuated flexure stage capable of 5 μm deflection in
both axes. The high-speed flexure stage was mounted on a stick-slip x-y
positioner for coarse alignment (Smaract). Typically, images of size 5 μm
 5 μm, 1000px  1000px, were captured in raster mode and rendered
using customised LabView software. Each image was captured in 0.5s
(two frames per second).
The original, as-received surface finish proved to be too rough for the
HS-AFM technique. Therefore, analysis concentrated on imaging control
(blank) and 2 μM FHBP-coated polished specimens, as informed from our
previous work pertaining to the functionalisation of HAp with FHBP
[27].
HS-AFM specimens were analysed as-received and stored between
measurements under ambient laboratory conditions.
Surface wettability measurements
Static contact angle measurements were taken using the Model
68–76 Pocket Goniometer PGXþ and PGXþ software (Testing Machines
Inc. New Castle, Delaware, USA) operated from a laptop computer.
Droplets (4 μl) of cell culture-grade water were used to determine the
surface wettability of control and FHBP-functionalised Ti6Al4V sample
discs.
The osteoblast cell culture model
Human MG63 osteoblast-like cells (ECACC, item code: 86051601)
were cultured in conventional tissue culture flasks (750 mL, Greiner,
Frickenhausen, Germany) in a humidified atmosphere at 37 C and 5%
CO2. Cells were grown to confluence in Dulbecco’s modified Eagle me-
dium (DMEM)/F12 nutrient mix (Gibco, Paisley, Scotland) supplemented
with sodium pyruvate (1 mM final concentration), L-glutamine (4 mM),
streptomycin (100 ng/mL), penicillin (0.1 units/mL) and 10% v/v foetal
calf serum (Gibco, Paisley, Scotland). The growth media was also sup-
plemented with 1% v/v of a 100 stock of non-essential amino acids. For3
experimental purposes, MG63 cells were seeded and maintained in the
same growth medium but devoid of both serum and phenol red [serum-
free culture medium (SFCM)].
Identified below are each of the different steps taken to develop and
determine the efficacy of FHBP-Ti6Al4V to support 1,25D-induced
osteoblast maturation. In some instances, Ti6Al4V dental screws were
substituted for Ti6Al4V discs. For the purposes of clarity, all control and
FHBP-functionalised samples were seeded with 1 ml of a 150,000 cells/
ml suspension of MG63 cells in SFCM spiked with 1,25D to a final
concentration of 100 nM. Cell- Ti6Al4V cultures were subsequently left
for 3 days under conventional culturing conditions prior to an assess-
ment of cellular maturation, as determined via total alkaline phospha-
tase (ALP) activity as detailed by us previously [20,27].
Biological optimisation of Ti6Al4V
Determining the optimal FHBP concentration
Ti6Al4V discs (10 mm  2 mm), kindly provided by Corin (Ciren-
cester, UK) were given a thorough distilled water rinse followed by a
brief (2 min) immersion in concentrated nitric acid with gentle swirling.
After thorough rinsing with distilled water, the samples were placed in
aluminium foil trays and baked at 180 C for 3 days. FHBP (LPA
analogue, item code: L-9118-0.5 mg, Tebu-bio Ltd. Peterborough, UK)
was reconstituted to 500 μM using 1:1 ethanol: cell culture-grade water
and stored at –20 C. For ascertaining the optimal FHBP steeping con-
centration for Ti6Al4V functionalisation, sample discs were placed into
24-well tissue culture plates and exposed to varying concentrations of
FHBP (0.25 μM–5 μM) for a period of 24 h. Cell culture-grade water was
used as the diluent. Unmodified, control Ti6Al4V discs were immersed in
cell culture-grade water.
Discs were removed from the wells after 24 h and were rinsed three
times in cell culture-grade water before being left to air dry within the
tissue culture hood. Once dried they were transferred to a clean 24-well
plate and seeded with MG63 cells. The optimal FHBP steeping concen-
tration identified (2 μM) was used for all subsequent experiments. This
test was performed in triplicate with n ¼ 6 samples per time point with
each test performed on different days and using a different passage
number of cells.
Ascertaining the optimal FHBP steeping time
Cleaned and baked Ti6Al4V discs were transferred to 24-well plates.
Then 1 ml of 2 μM FHBP solution was added per well and discs were
steeped for a specified time period (15 min, 1 h, 2 h, 4 h or 24 h) in the
solution. Control discs were steeped in the vehicle for the specified time
period. The discs were removed from the wells after steeping and were
rinsed three times in cell culture-grade water before being left to air dry.
Once dried, they were transferred to clean 24-well plates and seeded with
MG63 cells in the presence of 1,25D (100 nM). The optimal steeping time
identified was used for all subsequent experiments. This experiment was
performed in triplicate with n ¼ 6 discs per time point for each test.
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morphology and maturation
Ti6Al4V discs were steeped in a 2 μM solution of FHBP for 2 h.
Control discs were steeped in diluent only. Modified and control discs
were then rinsed three times in cell culture-grade water and left to air
dry. Once dried, the discs were transferred to 24-well plates and seeded
with MG63 cells using a serum-free culture medium supplemented with
1,25D to a final concentration of 100 nM.
Assessing the impact of γ-irradiation on coating efficacy
Three batches of 12 Ti6Al4V discs were steeped, on three different
days, in a 2 μM solution of FHBP for 2 h. Once modified, washed and
dried, half of each batch were placed in small sealable plastic bags and
dispatched to Synergy Health (Swindon, UK) for γ-irradiation, as would
be expected for medical device sterilisation. Sample discs received an
outside dosing exposure of γ-irradiation until the dosimeter registered 35
kGy. An exposure time of 19 h was required to achieve this. The
remaining Ti6Al4V samples were left stored under ambient conditions.
Non-irradiated control, blank and irradiated specimens were seeded with
MG63 cells. Each of the different batches was exposed to cells on
different days to generate three independent experiments.
Long-term ambient storage survivorship
Ti6Al4V discs were steeped in a 2 μM solution of FHBP for 2 h.
Control discs were steeped in the diluent only. Discs were either seeded
with MG63 cells within 24 h of modification or stored in air for up to 2
years before conducting the cell culture experiments. Three independent
experiments were performed for each of the different storage times.
Persistence of the FHBP coating to a simulated in vivo milieu
Ti6Al4V discs were steeped in 2 μM FHBP solution for 2 h. Control
discs were immersed in diluent only. The discs were then individually
placed within wells of a 24-well culture plate and the samples immersed
in 1 ml of SFCM (see Section Physiochemical characterisation of FHBP-
functionalised Ti6Al4V) and placed in a tissue culture incubator at 37
C for 1, 3 and 7 days. After the incubation period, the SFCM was
removed, spiked with 1,25D to a final concentration of 100 nM and
applied to established monolayers of MG63 cells. Cells were cultured for
three days prior to an assessment of their maturation via total alkaline
phosphatase (ALP) assay. Each of the FHBP-Ti6Al4V discs that were
steeped in SFCM were seeded with MG63 cells in the presence of 1,25D
(100 nM) and left for 3 days prior to an assessment of total ALP activity.
FHBP-Ti6Al4V coating stability to Sawbone™ insertion
Ti6Al4V dental screws, kindly provided by OsteoCare (Slough, UK),
were used to ascertain the effect of physical insult on FHBP coating
stability. Three batches of 12 screws were steeped, on three different
days, in a 2 μM aqueous FHBP solution for 2 h. Control screws were
immersed in water only. Half of each batch was inserted into a mock
cancellous bone substitute, Sawbone™ (item code: 1522-27 50PCF),
comprising a solid, rigid, polyurethane foam. The substitute conforms to
American Society for Testing and Materials (ASTM) F-1839-08 making itTable 2












a ‘standard material for testing orthopaedic devices and instruments’.
The mechanical properties of this substitute (Table 2) place it as ‘an ideal
material for comparative testing of bone screws and other medical de-
vices and instruments’. A dental drill (NSK EC BB-L) operated with a
Model XP-90 power supply was used to make pilot holes in a block of the
material, and the test specimens screwed in place. Once inserted, the
screws were removed and cleaned under running tap water for approx-
imately 30 s with an electrical toothbrush (ProclinicalTM C250, Colgate).
Sample screws were then distilled water washed by shaking in clean
universal tubes before being given three separate rinses in 70% ethanol.
Samples were left to dry in a laminar flow hood before seeding with
osteoblasts. A total of three independent Sawbone™ insertion experi-
ments were performed.
Biomaterial tissue culture model
For each of the above experiments, Ti6Al4V samples were individu-
ally placed within wells of 24-well culture plates and seeded with 1 ml of
a 150,000 cells/ml suspension of MG63 cells in SFCM spiked with cal-
citriol (1,25D, Sigma, item code: D1530-10UG) to a final concentration of
100 nM. Plates were incubated under conventional tissue culture con-
ditions for 72 h before an assessment of osteoblast cell number and
maturation.
Assessment of osteoblast number
An assessment of cell number was performed as described by us
recently [27] using a combination of the tetrazolium compound 3-(4,
5-dimethylthiazol-2-yl)-5-(3-carboxymethox-
y-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS, Promega,
UK) and the electron-coupling reagent phenazine methosulphate (PMS).
Each compound was prepared separately in pre-warmed (37 C) phenol
red-free DMEM/F12, allowed to dissolve, and then combined so that 1 ml
of a 1 mg/ml solution of PMS was combined to 19 ml of a 2 mg/ml so-
lution of MTS. A stock suspension of MG63s (1  106 cells/ml) was
serially diluted in growth medium to give a series of known cell con-
centrations down to 25  103 cells/mL. Each sample (0.5 ml in a
microcentrifuge tube) was spiked with 0.1 ml of the MTS/PMS reagent
mixture and left for 45 min within a tissue culture incubator. Once
incubated, the samples were centrifuged at 900 rpm to pellet the cells,
and 0.1 ml of the supernatants dispensed onto a 96-well microtitre plate
and the absorbances read at 492 nm using a multiplate reader. Plotting
the absorbances against known cell numbers, as initially assessed
through haemocytometry, enabled extrapolation of cell numbers for the
experiments described herein.
Osteoblast maturation – the alkaline phosphatase (ALP) assay
An ALP substrate buffer was prepared, according to Delory and King
[28]. Briefly, 0.1 M sodium carbonate and 0.1 M sodium bicarbonate
solutions were blended 7:3 to achieve a pH of 10.3. The resultant solution
was supplemented with MgCl2 to a final concentration of 1 mM from a 1
M stock solution. A lysis solution was prepared from this buffer by per-
forming a 10-fold dilution using cell culture-grade water followed by
spiking with Triton X-100 to a final concentration of 0.1% v/v. The
monolayers on the surface of the Ti6Al4V discs were lysed with 0.1 ml of
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ALP buffer. Lysates were left under conventional cell culturing conditions
for an hour. After the incubation period, 0.1 ml aliquots were transferred
to 96-well microtitre plates, and the absorbances read at 405 nm. An
ascending series of p-nitrophenol (p-NP) (50–500 μM) prepared in the
substrate buffer enabled the quantification of product formation [27].
Osteoblast morphology at control and FHBP-Ti6Al4V
Cells were seeded onto control and FHBP-Ti6Al4V as per all previous
experiments. After the culture period recovered samples were fixed in
2.5% paraformaldehyde in PBS for 5 min at room temperature. Once
fixed, the cells were exposed to a 40,6-Diamidino-2-phenylindole dihy-
drochloride (DAPI) mountant (Vector Laboratories Ltd., Peterborough,
UK) to visualise nuclei and counterstained with Alexa Fluor™ 5945
Phalloidin (Fisher Scientific Limited, Loughborough, UK) to detect F-
actin. Cells were visualised with a Nikon Eclipse 80i (Nikon Instruments
Inc., Melville, USA) fluorescence microscope with a 60  objective and
images taken using a DS-Fi1 5Mega pixel RGB camera (Nikon UK
Limited, Kingston upon Thames, UK).
Statistical analysis
Results are expressed as mean  standard deviation (SD). Statistical
analyses were performed using GraphPad Prism 7.00 software. Unless
otherwise stated, all data were subjected to a one-way analysis of vari-
ance (ANOVA) to test for statistical significance. A post hoc Tukey’s
multiple comparisons test was performed between all groups where a p-
value of <0.05 was detected. An unpaired t-test (2-tailed) was used to
compare means of modified and unmodified discs and of freshly used andFigure 2. Negative ion SIMS spectra of fresh, pol-
ished Ti6Al4V specimen surfaces: A) Control
(blank); B) 2 μM FHBP-coated – Small discs of
freshly polished and coated Ti6Al4V material were
analysed by secondary ion mass spectrometry, using a
focused gallium ion beam as the primary ion source.
Emitted secondary ions were collected and mass-
analysed to produce the spectra shown above. Peaks
with mass/charge ratios of 1, 12, 13, 14, 16, 17, 19,
24, 25 and 26 arise from negatively-charged second-
ary ions H, C, CH, CH2, O, OH, F, C2, C2H and CN,
respectively. SIMS is very surface sensitive, with the
depth of analysis being only 1–2 atom layers. The
fluorine peak at mass/charge ¼ 19 in the lower figure
is indicative of the FHBP coating adhering to the sur-
face of the sample. An indication of FHBP coverage is
calculated from the ratio of the F (mass 19) to the O
(mass 16) peaks, to account for variations in instru-
ment sensitivity.
Figure 3. Surface topography of FHBP-Ti6Al4V – A. Negative ion fluorine peak (mass/charge ¼ 19) SIMS map of 2 μM FHBP-coated, fresh, polished Ti6Al4V,
demonstrating that, apart from surface debris, fluorine (representative of FHBP) evenly covers the surface. The central black rectangle shows where a depth profile was
performed, etching away the fluorine-containing species. The image field width is ~400 μm. B. SIMS fluorine to oxygen (mass/charge ¼ 16) peak height ratios for as-
received and polished Ti6AL4V, blank and 2 μM FHBP-coated, as a function of measurement date - The two blank (untreated) samples show low values, though non-
zero in the as-received material due to some fluorine contamination. 2 μM FHBP-treated Ti6AL4V shows high values, indicating the continuing presence of FHBP over
two years. C. HS-AFM height maps of fresh, polished Ti6Al4V: i) Control (blank); ii) 2 μM FHBP-coated - The larger polygonal shapes are a harder phase of the Ti6AlV
left proud of the surrounding material due to polishing rate differences. The smaller high features are likely contaminants and residue from the polishing and FHBP
coating steps. D. HS-AFM measurement of 2 μM FHBP coating thickness - Line profile across a transition from coating to bare Ti6AlV surface created by mechanical
scraping, showing the film to be ~1.5 nm thick.
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Results
Magnetic sector secondary ion mass spectrometry
Positive and negative SIMS spectra, depth profiles and maps were
obtained from as-received and polished Ti6Al4V specimens that were
either untreated or had been treated with aqueous 2 μM FHBP. Negative
ion spectra, via their ratios of the peak heights for fluorine (19Da) and
oxygen (16Da), confirm the presence of FHBP on the surfaces of coated
specimens (Fig. 2). A negative ion SIMS map of fluorine for 2 μM-coated
polished specimens demonstrates that the FHBP is evenly distributed
across the surface (Fig. 3A). We also monitored coating stability, looking
to see if there were any signs of reduction of the amount of surface
coating. The ratios of the peak heights for fluorine (19Da) and oxygen
(16Da), for as-received and polished specimens, and as a function of the
measurement date, are shown graphically (Fig. 3B). This ratio was taken
to correct for any changes in absolute signal strength from specimen to
specimen. Similar information can be obtained by looking at maps of the
distribution of these elements across the sample surface. We have been
able to analyse the same areas on the same specimens over a period of
almost two years. In the vast majority of cases, both spectra and maps
have remained consistent throughout the duration of the project, indic-
ative of the continuing presence of the active coating on the specimen
surfaces.6
High-speed atomic force microscopy (HS-AFM)
The HS-AFMmicrographs (Fig. 3C) represent the fresh control (blank)
and 2 μM FHBP-coated specimens. In both cases, the major contrast
differences seen are due to surface height differences in the polished
discs, in turn, attributed to different hardnesses present within the two-
phase Ti6Al4V alloy material. However, in addition, the presence of
the surface coating was clearly evident in images of the 2 μM FHBP
specimen. The coating was found to be ubiquitous across the sample
surface and very durable. Attempts to scratch through with the AFM
cantilever failed. However, the layer did seem to consist of a porous
structure rather than a homogeneous coating. Scaling these images to the
same height range and recording line profile across the specimens
revealed the coating to increase the roughness of the surface noticeably
(Ra (uncoated)¼ 0.834 nm; Ra (coated)¼ 0.910 nm). When imaging the
2 μM FHBP-coated specimen two months later, the coating was found to
be more fragile andmore easily damaged by excessive tip-imaging forces.
This did, though, allow us, by using the HS-AFM probe tip, to scrape away
the surface film and create a measurable step height change. By these
means, it was then possible to show the film to be up to ~1.5 nm thick
(Fig. 3D). HS-AFM images obtained from the same areas (for the best
comparison of surfaces with time) on blank and 2 μM FHBP-coated pol-
ished Ti6Al4V specimens have largely shown no obvious signs of changes
in the active film with storage time. After many months of storage, there
were signs that gaps had started to appear in the coating, revealing the
underlying Ti beneath. Later images appeared to show the film to have
degraded somewhat. However, immediately-adjacent areas of the film
retained appearances akin to that of the original area when first imaged.
Figure 4. Contact angle measurements for bare
and FHBP-functionalised Ti6AL4V – Six clean
Ti6AL4V (Ti) discs (Blank-Ti) were randomly selected
from a batch of samples and six contact angle mea-
surements taken for each disc (64.14  3.28). All
discs were then steeped in a 2 μM aqueous solution of
FHBP for 2 h, retrieved, rinsed twice with distilled
water, and then allowed to dry in a laminar flow
cabinet. Once dried six contact angle measurements
were taken again for each of the sample discs
(FHBP–Ti). FHBP-functionalisation resulted in a
modest and significant increase (*p < 0.001) in the
contact angle by approximately 21% (77.95  3.32).
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consequence of repeated imaging rather than the effect of storage under
ambient conditions.
Coating Ti6Al4V with FHBP modestly increases surface hydrophobicity
Titanium discs (n ¼ 6) were randomly selected from a batch of
samples and six contact angle measurements taken for each disc (64.14
 3.28). All discs were then steeped in a 2 μM aqueous solution of FHBP
for 2 h, retrieved, rinsed twice with distilled water and allowed to dry.
Once dried, six contact angle measurements were taken again for each of
the sample discs. FHBP-functionalisation resulted in a modest and sig-
nificant increase (*p< 0.001) in the contact angle by approximately 21%
(77.95  3.32). Images taken for the water droplets at the control and
functionalised Ti6Al4V (Fig. 4) give a clear indication for a change in
surface wettability.
FHBP-functionalisation of Ti6Al4V produces a biologically active surface
finish
Informed from our previous work using HAp [27], we conducted a
pilot experiment wherein Ti6Al4V discs were exposed to aqueous FHBP
(0.5 – 2 μM) for a period of 24 h. Each of these different treatments
produced a functionalised surface that supported 1,25D-induced MG63
maturation, as determined via total ALP activity (Fig. 5A). Compared to
control metal, each of the FHBP-functionalised samples significantly
improved the maturation response by approximately 5 fold (p < 0.001).
Whilst the data indicate a modest improvement in the osteoblast
response at 2 μM FHBP-Ti6Al4V compared to 0.5 μM FHBP-Ti6Al4V, the
data did not reach statistical significance.
In the second set of pilot experiments, we examined the speed with
which FHBP could produce a functionalised Ti6Al4V surface capable of
enhancing 1,25D-induced osteoblast maturation. In light of the data
presented in Fig. 5A, we selected 2 μM FHBP as the steeping concentra-
tion for Ti6Al4V. The data presented support a good maturation response
of osteoblasts at Ti6Al4V surfaces exposed to FHBP for as little as 15 min
(Fig. 5B). Increasing the steeping time to 2 h culminated in a further
significant increase (p < 0.0001) in MG63 maturation compared to
control Ti6Al4V (p < 0.0001). An FHBP exposure time of 2 h appeared
optimal, and this was selected for the remaining experiments. An
assessment of MG63 morphology at the control and FHBP-Ti6Al4V
(Fig. 6) supported the expected change in cell shape consequent to LPA
receptor-mediated alterations in cytoskeletal dynamics. Cells at FHBP-
Ti6Al4V were slightly larger, and the signal intensity for F-actin was
noticeably more intense.
FHBP-Ti6Al4V is stable to prolonged ambient storage
Orthopaedic and dental Ti6Al4V devices are stored packaged, in air,
under ambient conditions, often for many months prior to implantation.
We, therefore, examined the efficacy of FHBP-Ti6Al4V to enhance 1,25D-
induced osteoblast maturation following prolonged ambient storage. The7
data presented (Fig. 7) clearly indicate that compared to control metal,
FHBP-Ti6Al4V continues to bolster MG63 maturation even after 2 years
of storage (p < 0.0001).
FHBP-functionalised Ti6Al4V withstands γ-irradiation, insertion into
Sawbone™ and exposure to a simulated in vivo milieu
Medical implants are invariably sterilised using γ-irradiation. Typical
outside dosing can be in the range of 25–35 kGy for joint prostheses.
FHBP-functionalised Ti6Al4V was examined for its ability to support
1,25D-induced osteoblast maturation following 35 kGy outside dosing
(Fig. 8A). As anticipated, non-irradiated functionalised surfaces sup-
ported a good maturation response compared to bare metal (p< 0.0001).
Similarly irradiated FHBP-Ti6Al4V secured a clear maturation response
of MG63 cells compared to non-functionalised controls (p < 0.0001).
However, over the three independent experiments, we consistently found
a modest, yet statistically significant reduction (p < 0.001), in the ability
of irradiated samples to support 1,25D-induced cellular maturation
compared to non-irradiated functionalised controls. On average, this
decline in potency was approximately 25%.
Next, we examined the robustness of the FHBP coating to withstand
the rigours of insertion into a solid block of Sawbone™. For these
particular tests, dental screws fashioned from the same Ti6Al4V alloy
were used. The evidence presented (Fig. 8B) indicates that FHBP-
functionalised Ti6Al4V screws retain bioactivity after mock bone im-
plantation, retrieval and washing. Importantly the ability of implanted
and non-inserted functionalised controls to enhance 1,25D-induced
MG63 maturation was similar. Collectively the findings presented indi-
cate an FHBP coating that demonstrates good survivorship to physical
insult.
In a final set of experiments, we examined if the FHBP coating was
retained on the Ti6Al4V surface following a 1 week exposure to SFCM at
37 C. When MG63 cells were seeded onto these SFCM-treated discs, the
extent of maturation, as determined via total ALP activity, was compa-
rable to cells at untreated FHBP-Ti6Al4V surfaces (Fig. 9A). The recov-
ered, conditioned, SFCM (CM) was spiked with 1,25D to a final
concentration of 100 nM and applied to established monolayers of cells.
From the data provided (Fig. 9B), it would appear that little/no FHBP had
leached from the functionalised Ti6Al4V as the extent of cellular matu-
ration was comparable to cells treated with FHBP (250 nM) alone.
Discussion
Aseptic loosening of TJRs is expected to increase given the prediction
of a rise in the elderly demographic. Reducing the socioeconomic impact
of revision arthroplasties for these implant failures is, therefore, an
ongoing area of active research and development. Improving the
longevity of TJR technologies could include simple biological coatings
aimed at encouraging early, enhanced osseointegration. Simple solutions
that deliver on these properties are more likely to be adopted by the
implant manufacturers compared to more complex, costly and time-
consuming strategies.
Figure 5. Direct functionalisation of Ti6AL4V with
FHBP supports 1,25D-induced osteoblast matura-
tion – A. Orthopaedic-grade Ti6AL4V (Ti) discs (12
mm diameter, 1 mm thick) were individually housed
in multiwell plates and steeped in aqueous solutions of
FHBP (0.5 – 2 μM) for 24 h. After rinsing and drying,
all discs were seeded with MG63 osteoblasts at a
density of 15  104 cells/ml/disc in the presence of
100 nM 1,25D. After a 3-day culture, an assessment of
MG63 maturation was determined via a total alkaline
phosphatase (ALP) assay. Greater concentrations of p-
nitrophenol (p-NP) generated from the hydrolysis of p-
nitrophenyl phosphate are indicative of raised ALP
activity, a feature of mature osteoblasts. Depicted are
the pooled data from three independent experiments.
Each bar (N ¼ 18) represents the mean micromolar
concentration of p-NP plus the standard deviation. An
FHBP steeping concentration as low as 500 nM
generated Ti6AL4V surfaces that were superior to
control (CTRL)-Ti (*p < 0.001) at supporting 1,25D-
induced MG63 maturation. B. An FHBP (2 μM)
steeping time of only 15 min generated Ti6AL4V sur-
faces that were superior to CTRL-Ti (**p < 0.001) at
supporting 1,25D-induced MG63 maturation. By
increasing the steeping time for a further 105 min
added a significant (*p ¼ 0.001) improvement in the
maturation response. The data depicted are repre-
sented from two independent experiments and are
expressed as the mean micromolar concentration of p-
NP plus the standard deviation. For each bar N ¼ 6.
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oblast formation and maturation is certainly nothing new. Indeed
osteoinductive bone morphogenic proteins (BMPs), for example, have
been considered attractive candidates for bone biomaterial functionali-
sation for approximately two decades [32,33]. However, getting those8
molecules securely fastened in a functional, reversibly bound form is
especially challenging, particularly if they are large protein growth fac-
tors; rigid linkages between the protein and the material surface can lead
to loss of function consequent to tertiary structure collapse [34]. In
addition, many of the steps taken to secure these factors at the metal
Figure 6. MG63 cell morphology at FHBP-
functionalised Ti6AL4V – Cells were seeded onto
control (Blank-Ti) and FHBP-functionalised Ti6AL4V
(FHBP–Ti) and cultured, under conventional condi-
tions for 3 days. Once cultured, the sample discs were
recovered, fixed in paraformaldehyde and the cells
stained to visualise nuclei (DAPI) and F-actin (Alexa
488). In keeping with the reported effects of LPA
(FHBP) on the cytoskeleton, it is clear that MG63 cells
are slightly larger at FHBP-Ti surfaces and exhibit
more intense staining for F-actin. Scale bar: 20 μM.
Figure 7. FHBP-functionalised Ti6AL4V is stable to prolonged ambient
storage in air – A total of 30 orthopaedic-grade Ti6AL4V (Ti) discs (12 mm
diameter, 1 mm thick) were individually housed in multiwell plates and steeped
in a 2 μM aqueous solution of FHBP for 2 h. Thirty control sample discs (CTRL-
Ti) were immersed in distilled water only for the same time. Within 48 h of
treatment (T ¼ 0) control and functionalised discs were seeded with MG63
osteoblasts at a density of 15  104 cells/ml/disc in the presence of 100 nM
1,25D. All other discs were transferred to sterile 24-well plates and stored under
ambient conditions in the air. At the desired time points, (6–24 months), control
and functionalised specimens were seeded with MG63 cells, as indicated above.
In each instance, the cells were cultured for 3-days under conventional condi-
tions, after which the discs were transferred to clean plates to assess osteoblast
maturation via a total alkaline phosphatase (ALP) assay. The data depicted for T
¼ 0, 12 and 24 months are the pooled data from three independent experiments.
For each bar N ¼ 18. Data for T ¼ 6 and 9 months are the pooled data from two
independent experiments. For each bar N ¼ 12. All data are expressed as the
mean micromolar concentration of p-NP plus the standard deviation. From the
findings presented, it is clear that at each time point, FHBP-Ti is better than
control metal at supporting osteoblast maturation (*p < 0.001).
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onerous, multistep operating conditions employing highly noxious re-
agents, e.g. Piranha solution (e.g. Ref. [36]). In the context of
BMP-2-functionalised Ti6Al4V, Kashigawi and colleagues [33] modified
this growth factor with a peptide motif (RKLPDA) known to bond elec-
trostatically to Ti6Al4V [37,38]. Such an approach comes at significantly
added cost to existing Ti6Al4V technologies, and to date, this novel,
innovative approach to improving Ti6Al4V prosthesis longevity has not
been adopted by any of the implant manufacturers.
Given some of the limitations that polypeptide/protein growth factors
have as Ti6Al4V coatings, e.g. susceptibility to proteases, supra-
physiological concentrations and/or possible immunogenic reactions, it
would be advantageous to utilise much smaller molecules. If these mol-
ecules, in turn, could be applied to Ti6Al4V (or indeed HAp) without the9
need for bespoke linkers and/or technically challenging procedures, then
they start to become far more appealing to the implant manufacturers.
The simplest growth factor known to target human osteoblasts and bone
marrow-derived stem cells is LPA [39]. Of particular significance to bone
health is our discovery that LPA, and certain LPA analogues, converge
with 1,25D to enhance human osteoblast formation and maturation [17,
19,20,24,25,40]. Fortuitously the LPAs are phosphonic acids, bearing
polar phospho-head groups, which have a natural affinity for TiO2, the
natural surface finish of the metal [22,23]. Their interaction with
Ti6Al4V affords the provision of securely fastened self-assembled layers
that are still able to signal transduce when osteoblasts arrive at the
functionalised surface [26].
Herein we present good evidence for the facile, direct modification of
Ti6Al4V with FHBP, a potent, phosphatase-resistant analogue of LPA. In
our experiments, we found that Ti6Al4V could be functionalised with
FHBP within 15 min using water as the solvent at room temperature.
Increasing the steeping time to 2 h afforded significant improvements in
surface functionality. Evidence of FHBP-Ti6Al4V functionality was based
on the ability of this surface to enhance 1,25D-induced osteoblast
(MG63) maturation, as supported by elevated total alkaline phosphatase
(ALP) activity. The enzyme is inextricably linked to bone matrix calcifi-
cation [41], and therefore, overall osteogenesis, forming an essential
aspect of bone biomaterial osseointegration. Biomaterial modifications
that induce significant increases in human osteoblast ALP are, therefore,
a very positive feature. The physiochemical evidence provided in this
report support the expected outcome for the interaction of TiO2 with
FHBP, as based on the known modes of phosphonic acid-binding to this
metal oxide [22]. From the SIMS and HS-AFM analysis results it is
evident, that for both ‘as-received’ and polished Ti6Al4V surfaces, that
the FHBP coating has remained present in significant quantities after
storage for at least two years under ambient conditions. We also found
that exposing FHBP to Ti6Al4V modestly reduced surface wettability
(77.95  3.32) by approximately 21% compared with unmodified
Ti6Al4V (64.14  3.28). This increase in the contact angle would be
expected for a Ti6Al4V surface coated with a lysophospholipid bearing
an oleoyl acyl chain.
In taking our first steps to realising the potential of FHBP-Ti6Al4V for
orthopaedic/dental applications, it is imperative that an assessment of
biomaterial stability be ascertained. To this end, we have focussed on
FHBP-coating stability to long-term (2 years) ambient storage, survi-
vorship to γ-irradiation and persistence of the Ti6Al4V coating following
insertion into a mock bone substitute, Sawbone™. With regard the latter,
this approach has been informed by our studies using juvenile porcine
mandibles and FHBP-functionalised dental screws [42]. We quickly
learned that the abundant ALP in the bone tissue rapidly adsorbed
(within minutes) to implanted Ti6Al4V screws. Since ALP is the endpoint
we had to source an alternative material to native bone tissue to bypass
Figure 8. FHBP-coating survivorship at Ti6AL4V following γ-irradiation
and insertion into a cancellous bone substitute – A. On three independent
occasions twelve orthopaedic-grade Ti6AL4V (Ti) discs (12 mm diameter, 1 mm
thick) were individually housed in multiwell plates and steeped in a 2 μM
aqueous solution of FHBP for 2 h. A dozen blank sample discs (Blank-Ti-Gamma)
were immersed in distilled water only for the same time. For each batch of blank
and functionalised specimens, half were stored under ambient conditions in air.
The remaining discs were dispatched for outside γ-irradiation dosing at ~35
kGy. Each batch of sample discs was seeded, on three separate days, with MG63
osteoblasts at a density of 15  104 cells/ml/disc in the presence of 100 nM
1,25D. After a 3-day culture, the discs were transferred to clean plates to assess
osteoblast maturation via a total alkaline phosphatase (ALP) assay. The data
depicted are the pooled data from three independent experiments and are
expressed as the mean micromolar concentration of p-NP per 100 k cells, plus
the standard deviation. For each bar N ¼ 18. As anticipated, non-irradiated
FHBP-Ti controls (FHBP–Ti-CTRL) were superior to blank discs in supporting
1,25D-induced cellular maturation. FHBP-functionalised discs that had been
irradiated (FHBP–Ti-Gamma) were also better than blanks in promoting 1,25D-
induced differentiation (**p < 0.0001) but they were significantly (*p < 0.001)
less potent than the FHBP-Ti-CTRL group. B. On three separate occasions,
twelve Ti6AL4V (Ti) dental screws (OseoCare, Slough, UK) were immersed in 2
μM aqueous FHBP for 2 h. Of these, half were implanted into a solid block of
mock bone (Sawbone™) using a dental drill. Once implanted, the screws were
retrieved, washed under running tap water to remove trapped particles and
subsequently prepared for osteoblast cell culture. As anticipated, non-inserted
functionalised samples (FHBP–Ti-CTRL) supported significantly greater 1,25D-
induced cell maturation (*p < 0.001) compared to unmodified dental screws
(Blank-Ti). Similarly, mock bone-inserted modified specimens (FHBP–Ti Saw-
bone™) supported greater MG63 maturation compared to blank-Ti (**p <
0.001). The similar extent of cellular maturation for both sets of functionalised
screws is evidence of coating survivorship to the rigours of implantation.
Figure 9. Evidence for the persistence of FHBP at a Ti6AL4V (Ti) surface
after a 7 day exposure to a simulated in vivo milieu – A. Ti6AL4V (Ti) discs
were functionalised with aqueous FHBP (2 μM) and either left ‘as is’ (Ti-FHBP)
or steeped in a serum-free cell culture medium (SFCM) for up to 1 week at 37 C.
At each of the indicated times, sample discs were recovered, rinsed, and seeded
with MG63 cells in the presence of 100 nM 1,25D and an assessment of total ALP
activity determined following a 72hr culture. The findings presented indicate
that each of the SFCM-treated Ti6AL4V samples exhibits comparable (ALP)
activity to the control, ‘as is’, Ti-FHBP. B. The conditioned SFCM (CM) recov-
ered from Ti-FHBP following a 7 day SFCM exposure were spiked with 1,25D to
a final concentration of 100 nM and applied to established monolayers of MG63
cells. Cultures were maintained for three days prior to total ALP activity assays.
As anticipated, the co-treatment of MG63 cells with 1,25D (100 nM) and FHBP
(250 nM) led to a clear increase in total ALP activity, as supported by the greater
concentration of p-nitrophenol (p-NP) generated from p-nitrophenyl phosphate.
In contrast, the 1,25D-supplemented CM was associated with a low total ALP
activity. Each data set is the pooled mean results from three independent ex-
periments (n ¼ 18), performed on different days, þ the SD.
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10the unavoidable contamination of our functionalised Ti6Al4V with this
enzyme. We, therefore, chose a cancellous bone surrogate (Sawbone™)
with material properties close to those of natural tissue (Table 2).
The findings presented in this report for Sawbone™-implanted
Ti6Al4V dental screws are encouraging as anticipated from our previous
work [42]; FHBP-Ti6Al4V dental screws supported a good maturation
response of osteoblasts to 1,25D. The extent of cellular maturation was
similar to FHBP-Ti6Al4V screws inserted into the cancellous bone sub-
stitute. In addition to these samples being inserted into Sawbone™,
retrieved screws were cleaned with an electric toothbrush under running
tap water. Collectively these findings indicate a robust coverage of FHBP
at the Ti6Al4V surface that has the potential to survive the rigours of
actual arthroplasty.
Total joint prostheses and Ti6Al4V dental implants are packaged for
ambient storage in air. Depending on the type of device and the age of the
recipient, some of these implants can remain stored for many months,
sometimes years. Whatever the biological coating type, it must be able to
withstand conventional storage for prolonged periods. We, therefore,
A.I. Shiel et al. Journal of Orthopaedic Translation xxx (xxxx) xxxexamined the biological performance of our FHBP-Ti6Al4V over a two-
year period. When osteoblasts were seeded onto these stored samples,
they were consistently superior to control, unmodified Ti6Al4V, at
enhancing 1,25D-induced cellular maturation. The extent to which the
cells differentiated after a two-year storage period was similar to freshly
functionalised Ti6Al4V. These are very encouraging findings, and we are
continuing to ascertain FHBP stability at Ti6Al4V for a further 3 years of
ambient storage.
Prior to their dispatch to the health services, packaged prostheses are
subjected to γ-irradiation to guarantee their sterilisation. Therefore,
during the course of our study, we subjected FHBP-functionalised
Ti6Al4V to 35 kGy outside dosing of γ-irradiation. Herein we provide
evidence that γ-irradiated FHBP-Ti6Al4Vwas better than control metal at
supporting 1,25D-induced cellular maturation. However, in contrast to
non-irradiated functionalised controls, γ-irradiation does impact nega-
tively on the biological activity of the adsorbed lipid. The extent of
reduced FHBP potency was fairly consistent and statistically significant
for each of the three independent experiments by approximately 25%.
The finding that the majority of the FHBP activity persisted soon (within
1 week) after ionising radiation is certainly encouraging. We also found,
from a single experiment, that irradiated FHBP-Ti6Al4V retained com-
parable activity to freshly irradiated samples even after 18 months of
ambient storage, suggesting little/no post-irradiation compromise to the
FHBP coating (data not shown).
Conclusion
During the course of our study, we found no reports detailing the
long-term stability and/or survivorship of any biological coating at a ti-
tanium surface. This is particularly surprising given the constraints
around medical device storage and use. To summarise, we have devel-
oped a biologically functionalised titanium surface finish that appears to
be stable to at least two years of ambient storage. The finding that the
Ti6Al4V -bound FHBP could withstand insertion into a mock bone sub-
stitute, resist irrigation and withstand γ-irradiation are important out-
comes in overall product development. The approach we have taken to
biologically functionalise titanium is very simple; a facile, dip coating
approach for (bio)material modifications is particularly attractive since
there is no requirement for specialist equipment, and the coating process
is not constrained to a specific feature [43–45]. These are important
considerations in realising the fabrication of new implantable Ti6Al4V
technologies which could now extend to bioactive phosphatase-resistant
LPA analogue coatings.
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